Published in Lancet on March 19, 1983
Diarrheagenic Escherichia coli. Clin Microbiol Rev (1998) 30.09
Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev (1989) 16.53
Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev (1998) 8.74
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med (2000) 7.78
Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. J Clin Microbiol (1986) 6.70
Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol (1999) 6.66
Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli. Infect Immun (1985) 5.04
Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511. Infect Immun (1991) 4.63
DNA fingerprinting of Escherichia coli O157:H7 strains by pulsed-field gel electrophoresis. J Clin Microbiol (1992) 4.24
Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov (2010) 4.23
Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome. J Clin Microbiol (1992) 3.57
Genome sequence analyses of two isolates from the recent Escherichia coli outbreak in Germany reveal the emergence of a new pathotype: Entero-Aggregative-Haemorrhagic Escherichia coli (EAHEC). Arch Microbiol (2011) 3.55
Infection of gnotobiotic pigs with an Escherichia coli O157:H7 strain associated with an outbreak of hemorrhagic colitis. Infect Immun (1986) 3.39
Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol (2003) 3.35
Survival and growth characteristics of Escherichia coli associated with hemorrhagic colitis. Appl Environ Microbiol (1984) 3.16
Cattle as a possible source of verocytotoxin-producing Escherichia coli O157 infections in man. Epidemiol Infect (1993) 2.94
Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin. J Clin Microbiol (1985) 2.70
Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infect Immun (1986) 2.64
Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands. Br Med J (Clin Res Ed) (1986) 2.47
Unusual verotoxin-producing Escherichia coli associated with hemorrhagic colitis. J Clin Microbiol (1987) 2.44
Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev (2013) 2.43
Shiga toxins--from cell biology to biomedical applications. Nat Rev Microbiol (2009) 2.19
Laboratory investigation of outbreak of hemorrhagic colitis caused by Escherichia coli O157:H7. J Clin Microbiol (1987) 2.17
Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome. J Clin Microbiol (1989) 2.08
Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect Immun (1991) 2.01
Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child (2001) 1.99
Production and characterization of a monoclonal antibody specific for enterohemorrhagic Escherichia coli of serotypes O157:H7 and O26:H11. J Clin Microbiol (1991) 1.95
Sporadic occurrence of hemorrhagic colitis associated with Escherichia coli O157:H7 in Newfoundland. CMAJ (1986) 1.86
Verotoxin-producing Escherichia coli infections in Sheffield: cattle as a possible source. Epidemiol Infect (1989) 1.78
Vero cytotoxin-producing Escherichia coli, particularly serogroup O 157, associated with human infections in the United Kingdom: 1989-91. Epidemiol Infect (1993) 1.78
Isolation of verocytotoxin-producing Escherichia coli from milk filters in south-western Ontario. Epidemiol Infect (1989) 1.77
Rapid hydrophobic grid membrane filter-enzyme-labeled antibody procedure for identification and enumeration of Escherichia coli O157 in foods. Appl Environ Microbiol (1988) 1.75
Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect Immun (1994) 1.72
A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators. Epidemiol Infect (1993) 1.72
Different classes of antibiotics differentially influence shiga toxin production. Antimicrob Agents Chemother (2010) 1.70
Pathogenic properties of Campylobacter jejuni: assay and correlation with clinical manifestations. Infect Immun (1985) 1.63
Real-time fluorescence PCR assays for detection and characterization of Shiga toxin, intimin, and enterohemolysin genes from Shiga toxin-producing Escherichia coli. J Clin Microbiol (2002) 1.61
Prevalence, antibiotic susceptibility, and diversity of Escherichia coli O157:H7 isolates from a longitudinal study of beef cattle feedlots. Appl Environ Microbiol (2001) 1.60
Escherichia coli O157:H7 in beef cattle presented for slaughter in the U.S.: higher prevalence rates than previously estimated. Proc Natl Acad Sci U S A (2000) 1.58
Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome. Clin Microbiol Rev (2004) 1.55
The use of sorbitol-MacConkey agar in conjunction with a specific antiserum for the detection of Vero cytotoxin-producing strains of Escherichia coli O 157. Epidemiol Infect (1988) 1.54
Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis. Clin Infect Dis (2016) 1.53
Molecular evolution of the intimin gene in O111 clones of pathogenic Escherichia coli. J Bacteriol (2002) 1.50
Phage-typing of Vero-cytotoxin (VT) producing Escherichia coli O157 isolated in the United Kingdom. Epidemiol Infect (1989) 1.50
Novel type of fimbriae encoded by the large plasmid of sorbitol-fermenting enterohemorrhagic Escherichia coli O157:H(-). Infect Immun (2001) 1.48
Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin. Infect Immun (2003) 1.44
Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant (2012) 1.44
Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection. J Biomed Biotechnol (2011) 1.42
Colitis in calves: natural and experimental infection with a verotoxin-producing strain of Escherichia coli O111:NM. Can J Vet Res (1988) 1.42
Sensitive receptor-specified enzyme-linked immunosorbent assay for Escherichia coli verocytotoxin. J Clin Microbiol (1989) 1.41
Haemolytic uraemic syndrome. Arch Dis Child (1984) 1.41
Hybridization of Escherichia coli producing Shiga-like toxin I, Shiga-like toxin II, and a variant of Shiga-like toxin II with synthetic oligonucleotide probes. Infect Immun (1989) 1.40
Intestinal adherence associated with type IV pili of enterohemorrhagic Escherichia coli O157:H7. J Clin Invest (2007) 1.39
Retracted Reanalysis of the gene expression profile in chronic pancreatitis via bioinformatics methods. Eur J Med Res (2014) 1.39
Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun (1992) 1.38
A christening party outbreak of haemorrhagic colitis and haemolytic uraemic syndrome associated with Escherichia coli O 157.H7. Epidemiol Infect (1989) 1.38
Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine. Infect Immun (1996) 1.37
Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-4. Epidemiol Infect (1996) 1.35
Enterohemorrhagic E. coli (EHEC) pathogenesis. Front Cell Infect Microbiol (2012) 1.35
Phage typing of Vero cytotoxin-producing Escherichia coli O 157 isolated in the United Kingdom: 1989-91. Epidemiol Infect (1993) 1.33
Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome. J Clin Microbiol (1992) 1.33
Comparison of a direct fecal Shiga-like toxin assay and sorbitol-MacConkey agar culture for laboratory diagnosis of enterohemorrhagic Escherichia coli infection. J Clin Microbiol (1992) 1.33
Peyer's Patches: The Immune Sensors of the Intestine. Int J Inflam (2010) 1.32
Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children. J Clin Microbiol (1992) 1.31
Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2. Infect Immun (1996) 1.30
A brief overview of Escherichia coli O157:H7 and its plasmid O157. J Microbiol Biotechnol (2010) 1.29
Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1. J Clin Microbiol (1994) 1.28
Identification of Escherichia coli serotype O157 strains by using a monoclonal antibody. J Clin Microbiol (1988) 1.26
Low-density macroarray targeting non-locus of enterocyte effacement effectors (nle genes) and major virulence factors of Shiga toxin-producing Escherichia coli (STEC): a new approach for molecular risk assessment of STEC isolates. Appl Environ Microbiol (2009) 1.26
Transduction of porcine enteropathogenic Escherichia coli with a derivative of a shiga toxin 2-encoding bacteriophage in a porcine ligated ileal loop system. Appl Environ Microbiol (2003) 1.26
Monoclonal antibodies for detection of the H7 antigen of Escherichia coli. Appl Environ Microbiol (1996) 1.26
Diarrhoea in close contacts as a risk factor for childhood haemolytic uraemic syndrome. The CPKDRC co-investigators. Epidemiol Infect (1993) 1.24
Serotypes of Escherichia coli that hybridized with DNA probes for genes encoding Shiga-like toxin I, Shiga-like toxin II, and serogroup O157 enterhemorrhagic E. coli fimbriae isolated from adults with diarrhea in Thailand. J Clin Microbiol (1990) 1.23
Rapid apoptosis induced by Shiga toxin in HeLa cells. Infect Immun (2003) 1.23
A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7. Proc Natl Acad Sci U S A (2002) 1.23
Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability. Am J Pathol (2005) 1.21
Haemorrhagic colitis: detection of verotoxin producing Escherichia coli O157 in a clinical microbiology laboratory. J Clin Pathol (1988) 1.21
Verotoxin and neuraminidase induced platelet aggregating activity in plasma: their possible role in the pathogenesis of the haemolytic uraemic syndrome. J Clin Pathol (1985) 1.19
Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome. J Clin Microbiol (2001) 1.18
Use of clustered regularly interspaced short palindromic repeat sequence polymorphisms for specific detection of enterohemorrhagic Escherichia coli strains of serotypes O26:H11, O45:H2, O103:H2, O111:H8, O121:H19, O145:H28, and O157:H7 by real-time PCR. J Clin Microbiol (2012) 1.18
Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents. J Clin Microbiol (1996) 1.18
Gene conservation and loss in the mutS-rpoS genomic region of pathogenic Escherichia coli. J Bacteriol (2000) 1.17
Role of the laboratory in the diagnosis of enterohemorrhagic Escherichia coli infections. J Clin Microbiol (2002) 1.17
Escherichia coli diarrhoea. J Hyg (Lond) (1985) 1.16
Epidemiology of Shiga toxin producing Escherichia coli in Australia, 2000-2010. BMC Public Health (2012) 1.16
Dipstick immunoassay to detect enterohemorrhagic Escherichia coli O157:H7 in retail ground beef. Appl Environ Microbiol (1992) 1.14
Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits. Infect Immun (1997) 1.12
Long term renal outcome of childhood haemolytic uraemic syndrome. BMJ (1991) 1.12
All blood, no stool: enterohemorrhagic Escherichia coli O157:H7 infection. J Vet Sci (2008) 1.11
Characterization and comparative genomic analysis of a novel bacteriophage, SFP10, simultaneously inhibiting both Salmonella enterica and Escherichia coli O157:H7. Appl Environ Microbiol (2011) 1.11
Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome. J Clin Microbiol (2002) 1.10
Antibody-based protection of gnotobiotic piglets infected with Escherichia coli O157:H7 against systemic complications associated with Shiga toxin 2. Infect Immun (1999) 1.10
The evolution of virulence in non-o157 shiga toxin-producing Escherichia coli. Front Microbiol (2011) 1.10
Sensitivities and specificities of premier E. coli O157 and premier EHEC enzyme immunoassays for diagnosis of infection with verotxin (Shiga-like toxin)-producing Escherichia coli. The SYNSORB Pk Study investigators. J Clin Microbiol (1998) 1.09
Effects of Escherichia coli Shiga-like toxins (verotoxins) in pigs. Can J Vet Res (1989) 1.09
Molecular epidemiology of Escherichia coli O157:H7 by restriction fragment length polymorphism using Shiga-like toxin genes. J Clin Microbiol (1995) 1.08
Antibodies to Escherichia coli O157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome. J Clin Pathol (1989) 1.08
Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS). BMC Med (2012) 1.07
Loop-mediated isothermal amplification assays for detecting shiga toxin-producing Escherichia coli in ground beef and human stools. J Clin Microbiol (2011) 1.07
Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality. Clin Exp Immunol (2000) 1.06
The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis (1985) 16.43
Campylobacter enteritis in children. J Pediatr (1979) 7.78
Bovine reservoir for verotoxin-producing Escherichia coli O157:H7. Lancet (1987) 5.63
Campylobacter enteritis. Can Med Assoc J (1979) 5.14
A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home. N Engl J Med (1987) 4.16
Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem (1987) 3.71
Transmissible plasmids from Campylobacter jejuni. Antimicrob Agents Chemother (1981) 3.05
Evaluation of a blood-free, charcoal-based, selective medium for the isolation of Campylobacter organisms from feces. J Clin Microbiol (1986) 2.79
Viruses associated with acute gastroenteritis in young children. Am J Dis Child (1977) 2.75
Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin. J Clin Microbiol (1985) 2.70
Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem Biophys Res Commun (1988) 2.65
Counter-immunoelectro-osmophoresis for the detection of infantile gastroenteritis virus (orbi-group) antigen and antibody. J Clin Pathol (1976) 2.63
Vero cytotoxigenic Escherichia coli infection in dairy farm families. J Infect Dis (1996) 2.56
The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol (1988) 2.51
Escherichia coli cytotoxin, haemolytic-uraemic syndrome, and haemorrhagic colitis. Lancet (1983) 2.44
Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrob Agents Chemother (1981) 2.43
Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter fetus subsp. fetus to eight cephalosporins with special reference to species differentiation. Antimicrob Agents Chemother (1980) 2.38
Surface properties of the Vero cytotoxin-producing Escherichia coli O157:H7. Infect Immun (1987) 2.34
Vesicular stomatitis virus--a new interfering particle, intracellular structures, and virus-specific RNA. Virology (1970) 2.22
The serotype and biotype distribution of clinical isolates of Campylobacter jejuni and Campylobacter coli over a three-year period. J Infect Dis (1983) 2.17
Solid-phase radioimmunoassay for the detection of rotavirus. Infect Immun (1977) 2.11
Cloning and expression of the genes specifying Shiga-like toxin production in Escherichia coli H19. J Bacteriol (1986) 2.04
Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile. J Hepatol (1999) 2.00
CREB-binding protein and histone deacetylase regulate the transcriptional activity of Kaposi's sarcoma-associated herpesvirus open reading frame 50. J Virol (2001) 1.96
Application of the Fortner principle to isolation of Campylobacter from stools. J Clin Microbiol (1979) 1.96
Experimental verocytotoxemia in rabbits. Infect Immun (1992) 1.94
Identification of minireovirus as a Norwalk-like virus in pediatric patients with gastroenteritis. J Virol (1994) 1.93
Outbreak of viral gastroenteritis due to a contaminated well. International consequences. JAMA (1997) 1.92
Development of verotoxin 2- and verotoxin 2 variant (VT2v)-specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F1. J Clin Microbiol (1991) 1.88
An outbreak of hemolytic uremic syndrome associated with ingestion of fresh apple juice. J Pediatr (1982) 1.88
Undescended testes: incidence in 1,002 consecutive male infants and outcome at 1 year of age. Pediatr Surg Int (1998) 1.87
Etiology of acute childhood encephalitis at The Hospital for Sick Children, Toronto, 1994-1995. Clin Infect Dis (1998) 1.85
Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex Transm Infect (2005) 1.81
Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.80
Acute childhood encephalitis and Mycoplasma pneumoniae. Clin Infect Dis (2001) 1.72
Human rotavirus enteritis induced in conventional piglets. Intestinal structure and transport. J Clin Invest (1977) 1.68
Social consensus through the influence of committed minorities. Phys Rev E Stat Nonlin Soft Matter Phys (2011) 1.67
Attempts to transmit campylobacter enteritis to dogs and cats. Can Med Assoc J (1978) 1.66
Direct isolation of atypical thermophilic Campylobacter species from human feces on selective agar medium. J Clin Microbiol (1989) 1.62
Diagnosis of fastidious enteric adenoviruses 40 and 41 in stool specimens. J Clin Microbiol (1984) 1.57
Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. J Biol Chem (1991) 1.53
Comprehensive PCR-based assay for detection and species identification of human herpesviruses. J Clin Microbiol (2000) 1.52
Laserlight cues for gait freezing in Parkinson's disease: an open-label study. Parkinsonism Relat Disord (2010) 1.51
Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015. Euro Surveill (2015) 1.50
Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem. Front Immunol (2012) 1.50
Fatal rotavirus gastroenteritis: an analysis of 21 cases. Am J Dis Child (1978) 1.49
Cost induced by hip fractures. Ir Med J (2008) 1.46
The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology (2000) 1.46
Serological differences between verocytotoxin 2 and shiga-like toxin II. Lancet (1988) 1.46
Purification and preliminary characterization of infantile gastroenteritis virus (orbivirus group). Intervirology (1975) 1.45
Isolation and characterization of sorbitol-fermenting Shiga toxin (Verocytotoxin)-producing Escherichia coli O157:H- strains in the Czech Republic. J Clin Microbiol (1998) 1.45
The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease. Br J Dermatol (2013) 1.44
Effect of dopamine on failure of indomethacin to close the patent ductus arteriosus. J Pediatr (1992) 1.44
Campylobacter pyloridis is associated with acid-peptic disease in Toronto. Can J Surg (1986) 1.42
Propagation of infantile gastroenteritis virus (orbi-group) in conventional and germfree piglets. Infect Immun (1975) 1.39
Anticomplementary activity in serum of women with a history of recurrent pregnancy loss. Am J Obstet Gynecol (1988) 1.39
Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family. Am J Physiol Gastrointest Liver Physiol (2000) 1.37
Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium. J Med Genet (2000) 1.35
Antigenic heterogeneity of Escherichia coli verotoxins. Lancet (1986) 1.35
Influenza A outbreak in a nursing home: the value of early diagnosis and the use of amantadine hydrochloride. Can J Infect Control (1994) 1.34
From the National Institutes of Health. Summary of the International Symposium and Workshop on Infections due to Verocytotoxin (Shiga-like toxin)-producing Escherichia coli. J Infect Dis (1988) 1.34
Human Escherichia coli O157:H7 infection associated with the consumption of unpasteurized goat's milk. Epidemiol Infect (1997) 1.34
Enteric adenoviruses: detection, replication, and significance. J Clin Microbiol (1979) 1.32
Rotavirus-associated diarrhea in outpatient settings and child care centers. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. Arch Pediatr Adolesc Med (2000) 1.32
Lapine rotavirus: preliminary studies on epizoology and transmission. Can J Comp Med (1978) 1.30
Hospitalization for community-acquired, rotavirus-associated diarrhea: a prospective, longitudinal, population-based study during the seasonal outbreak. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. Arch Pediatr Adolesc Med (2000) 1.28
Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1. J Clin Microbiol (1994) 1.28
Free energy decomposition of protein-protein interactions. Biophys J (2001) 1.27
Six-year retrospective surveillance of gastroenteritis viruses identified at ten electron microscopy centers in the United States and Canada. Pediatr Infect Dis J (1990) 1.25
The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome. Mol Endocrinol (2001) 1.24
Nebulized albuterol in acute bronchiolitis. J Pediatr (1990) 1.23
Longitudinal study of molecular epidemiology of small round-structured viruses in a pediatric population. J Clin Microbiol (1996) 1.22
Abortion and perinatal sepsis associated with campylobacter infection. Rev Infect Dis (1986) 1.22
Etiology of community-acquired pediatric viral diarrhea: a prospective longitudinal study in hospitals, emergency departments, pediatric practices and child care centers during the winter rotavirus outbreak, 1997 to 1998. The Pediatric Rotavirus Epidemiology Study for Immunization Study Group. Pediatr Infect Dis J (2000) 1.20
Accuracy and precision of NMR relaxation experiments and MD simulations for characterizing protein dynamics. Proteins (1997) 1.19
California encephalitis virus development in mosquitoes as revealed by transmission studies, immunoperoxidase staining, and electron microscopy. Can J Microbiol (1975) 1.19
A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol (2008) 1.18
Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome. J Clin Microbiol (2001) 1.18
Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. Euro Surveill (2013) 1.18
Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents. J Clin Microbiol (1996) 1.18
Pathology of the vitamin C deficiency syndrome in channel catfish (Ictalurus punctatus). J Nutr (1978) 1.16
Evaluation of a microplate latex agglutination method (Verotox-F assay) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli. J Clin Microbiol (1999) 1.16
Controlled study of respiratory viruses and wheezing. Arch Dis Child (2002) 1.15
Early-onset osteoarthritis of mouse temporomandibular joint induced by partial discectomy. Osteoarthritis Cartilage (2009) 1.14
Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med (1991) 1.13
Acute cytomegalovirus infection in a child with Ménétrier's disease. Gastroenterology (1995) 1.12